Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $20.55M.
ENTERPRISE VALUE (EV)
$20.55M
BriaCell Therapeutics Corp.
Market Cap
$34.97M
Enterprise Value (EV)
$20.55M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | $34.97M | $20.55M |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.52M | $28.88M |
| Elutia Inc (ELUT)vs › | $34.35M | $25.24M |
| DocGo Inc. (DCGO)vs › | $35.76M | $36.43M |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | $25.50M |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | $26.51M |
| EUDA Health Holdings Limited (EUDA)vs › | $36.21M | $38.27M |
| Scilex Holding Company (SCLX)vs › | $33.63M | $128.62M |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | $19.85M |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | $6.42M |
Market Cap
$34.97M
Total Debt
$0.00
Cash
$14.43M
Enterprise Value
$20.55M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
